Stone Run Capital, LLC Edwards Lifesciences Corp Transaction History

Stone Run Capital, LLC

  • $250 Billion
  • Q2 2024

A detailed history of Stone Run Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stone Run Capital, LLC holds 79,325 shares of EW stock, worth $5.36 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares
79,325
Previous 77,850 1.89%
Holding current value
$5.36 Million
Previous $7.44 Billion 1.51%
% of portfolio
2.93%
Previous 2.84%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$84.3 - $94.31 $124,342 - $139,107
1,475 Added 1.89%
79,325 $7.33 Billion
Q1 2024

May 14, 2024
SELL
$72.54 - $95.56 $141,453 - $186,342
-1,950 Reduced 2.44%
77,850 $7.44 Billion
Q4 2023

Feb 14, 2024
BUY
$61.71 - $77.76 $283,866 - $357,696
4,600 Added 6.12%
79,800 $6.08 Billion
Q3 2023

Nov 14, 2023
BUY
$69.28 - $93.38 $5.21 Million - $7.02 Million
75,200 New
75,200 $5.21 Billion
Q4 2022

Feb 14, 2023
SELL
$68.3 - $87.44 $109,280 - $139,904
-1,600 Reduced 2.09%
75,025 $5.6 Million
Q3 2022

Nov 14, 2022
SELL
$82.37 - $107.29 $123,555 - $160,935
-1,500 Reduced 1.92%
76,625 $6.33 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $1.05 Million - $1.55 Million
-12,100 Reduced 13.41%
78,125 $7.43 Million
Q1 2022

May 16, 2022
BUY
$101.96 - $128.34 $101,960 - $128,340
1,000 Added 1.12%
90,225 $10.6 Million
Q4 2021

Feb 14, 2022
SELL
$106.37 - $130.68 $389,314 - $478,288
-3,660 Reduced 3.94%
89,225 $11.6 Million
Q3 2021

Nov 15, 2021
SELL
$102.91 - $122.75 $14,407 - $17,185
-140 Reduced 0.15%
92,885 $10.5 Million
Q2 2021

Aug 16, 2021
BUY
$83.84 - $104.76 $41,920 - $52,380
500 Added 0.54%
93,025 $9.64 Million
Q1 2021

May 17, 2021
SELL
$78.68 - $90.67 $55,076 - $63,469
-700 Reduced 0.75%
92,525 $7.74 Million
Q3 2020

Nov 13, 2020
SELL
$67.19 - $87.44 $40,314 - $52,464
-600 Reduced 0.64%
93,225 $7.44 Million
Q2 2020

Aug 14, 2020
BUY
$57.54 - $76.95 $3.49 Million - $4.67 Million
60,650 Added 182.82%
93,825 $6.48 Million
Q1 2020

May 15, 2020
SELL
$52.41 - $81.0 $217,501 - $336,150
-4,150 Reduced 11.12%
33,175 $6.26 Million
Q4 2019

Feb 14, 2020
SELL
$71.7 - $82.09 $102,172 - $116,978
-1,425 Reduced 3.68%
37,325 $8.71 Million
Q3 2019

Nov 14, 2019
SELL
$61.55 - $75.43 $12,310 - $15,086
-200 Reduced 0.51%
38,750 $8.52 Million
Q4 2018

Feb 14, 2019
SELL
$46.41 - $56.94 $371,280 - $455,520
-8,000 Reduced 17.04%
38,950 $5.97 Million
Q1 2018

May 14, 2018
SELL
$37.19 - $47.45 $55,785 - $71,175
-1,500 Reduced 3.1%
46,950 $6.55 Million
Q4 2017

Feb 15, 2018
SELL
$33.79 - $39.39 $97,991 - $114,231
-2,900 Reduced 5.65%
48,450 $5.46 Million
Q3 2017

Nov 14, 2017
BUY
$36.29 - $38.83 $1.86 Million - $1.99 Million
51,350
51,350 $5.61 Million

Others Institutions Holding EW

# of Institutions
1,353
Shares Held
466M
Call Options Held
2.45M
Put Options Held
2.56M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email